Kumar, Dileep http://orcid.org/0000-0002-4774-6876
Bardooli, Fawaz
Chen, Wen-Jone
Huang, Dejia
Sankardas, Mullasari Ajit
Ahmed, Waqar Habib
Liew, Houng-Bang
Gwon, Hyeon-Cheol
Van Dorn, Brian
Holmes, Thomas
Thompson, Amy
Zhang, Shu
Funding for this research was provided by:
Medtronic
Article History
Received: 20 October 2023
Accepted: 1 June 2024
First Online: 7 June 2024
Declarations
:
: The protocol for the Improve SCA Bridge Trial was approved by the ethics committee at each participating institution and associated national and local regulatory agencies. All patients who participated in the trial provided written informed consent before undergoing study procedures.
: Not applicable.
: Dr Chen has received honorariums from Medtronic, Biotronik, Abbott, and Boston Scientific. Dr Huang has received speaker fees/consulting fees from Boston Scientific, Bayer, Boehringer-Ingelheim, and Abbott. Dr Liew has received speaker fees and honorarium from Medtronic and Boston Scientific. Brian Van Dorn, Dr Holmes, and Amy Thompson are employees of Medtronic Inc. Dr Zhang has received speaker fees/consulting fees from Boston Scientific, Medtronic, Abbott, and Biotronik and has received steering committee fees from Medtronic. All other authors have reported that there are no relationships relevant to the contents of this paper to disclose.